82822:HK:HK-CSOP FTSE China A50 (CNY)

ETF | Others |

Last Closing

USD 10.82

Change

0.00 (0.00)%

Market Cap

USD 7.65B

Volume

0.09M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-08-27 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
2800:HK Tracker Fund of Hong Kong

+0.17 (+0.96%)

USD 137.98B
2833:HK Hang Seng Index Tracking Fund

N/A

USD 30.97B
2828:HK Hang Seng China Enterprises In..

+0.50 (+0.81%)

USD 22.56B
2801:HK iShares Core MSCI China ETF

+0.15 (+0.85%)

USD 13.97B
2823:HK iShares FTSE A50 China

-0.09 (-0.75%)

USD 13.65B
83188:HK ChinaAMC CSI 300 Index ETF

-0.06 (-0.18%)

USD 13.48B
9067:HK iShares Hang Seng TECH ETF

+0.01 (+0.75%)

USD 9.22B
3067:HK iShares Hang Seng TECH ETF

+0.04 (+0.48%)

USD 9.22B
9010:HK iShares Core MSCI AC Asia ex J..

+0.08 (+1.10%)

USD 3.03B
9846:HK iShares Core CSI 300

-0.01 (-0.46%)

USD 2.96B

ETFs Containing 82822:HK

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 4.95% 73% C 73% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 4.95% 71% C- 71% C-
Trailing 12 Months  
Capital Gain -9.15% 55% F 60% D-
Dividend Return 2.85% 33% F 26% F
Total Return -6.30% 57% F 80% B-
Trailing 5 Years  
Capital Gain -17.91% 29% F 67% D+
Dividend Return 9.41% 70% C- 31% F
Total Return -8.50% 44% F 65% D
Average Annual (5 Year Horizon)  
Capital Gain -3.72% 60% D- 53% F
Dividend Return -1.67% 64% D 53% F
Total Return 2.05% 64% D 41% F
Risk Return Profile  
Volatility (Standard Deviation) 16.53% 58% F 81% B-
Risk Adjusted Return -10.09% 65% D 51% F
Market Capitalization 7.65B 71% C- 82% B

Annual Financials (CNY)

Quarterly Financials (CNY)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike